Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Intense pulsed light therapy to improve signs and symptoms of contact lens discomfort

IPL therapy, effectively reduced symptoms of CLD and improved meibomian gland function, though effect diminished within 69 days after the final treatment, underscoring the need for optimized treatment protocols.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors randomized 18 symptomatic contact lens wearers to intense pulsed light therapy or a sham treatment and assessed symptoms and eye measures over 90 days. The authors report that the IPL group had lower discomfort questionnaire scores and improved meibomian gland measures at 42 days, with several benefits diminishing by day 90. The sham group showed no significant changes.

Participants
18
Who or what was studied
Symptomatic contact lens wearers with a Contact Lens Dry Eye Questionnaire score of 12 or higher (36 eyes of 18 wearers; 20 eyes IPL, 16 eyes sham)
Limits stated in the abstract
The study was small, with 18 participants, and the abstract reports that the benefits diminished within 69 days after the final treatment.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Purpose

To evaluate the effects of Intense Pulsed Light (IPL) therapy on signs and symptoms of Contact Lens Discomfort (CLD) in symptomatic contact lens (CL) wearers.

Methods

A prospective, randomised, double masked study was conducted on 36 eyes of 18 CL wearers (IPL: n = 20; sham: n = 16) with a Contact Lens Dry Eye Questionnaire (CLDEQ-8) score ≥ 12. Participants received two IPL/sham treatments at three weeks intervals as per randomization. The sham group underwent simulated light exposure using a torch while the IPL device remained inactive. Meibomian gland expression was performed for both groups after each treatment. Symptom and clinical assessments included CLDEQ-8 questionnaire, non-invasive tear breakup time (NITBUT), tear film lipid layer thickness (TFLLT), tear meniscus height (TMH), tear volume, meibomian gland secretion score (MGSS), meiboscore (upper/lower eye lids), MG capping, pouting, foam, telangiectasia, hyperaemia (bulbar, limbal, & palpebral), palpebral roughness, corneal staining, and lid-parallel conjunctival folds (LIPCOF). Assessments were evaluated prior to treatment at baseline (D-0), and then at day 21(D-21), D-42, and D-90.

Results

The IPL group showed a significant reduction in CLDEQ-8 score from 18.1 ± 1.9 at D-0 to 10.7 ± 1.1 at D-42 (p = 0.01), and improved meibomian gland secretion score (MGSS) at D-21 (p = 0.02) and D-42 (p < 0.01), MG capping, and pouting remained improved at D-90 (p < 0.01). MG foam, telangiectasia, bulbar hyperaemia and corneal staining improved significantly at D-42 (p < 0.01), but most changes diminished by D-90. The sham group showed no significant changes. No differences were observed in tear film parameters at any time point.

Conclusion

IPL therapy, effectively reduced symptoms of CLD and improved meibomian gland function, though effect diminished within 69 days after the final treatment, underscoring the need for optimized treatment protocols.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Sham, Dry eye. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies